Go to content or main menu
News about medicines, policy and developments
Patients and consumers, healthcare providers, companies - human medicinal products, Novel Foods Unit
Marketing authorisation, production and distribution licenses, animal feeds, reporting (suspected) adverse events
Human and veterinary medicines information
Strategic objectives, organisation, network
Contact the MEB
11-07-2017 | 13:00
Commitment, continuity, connectivity and community – those are the keywords in the Dutch bid for the EMA.
15-06-2017 | 16:00
Today, the 2nd edition of the Regulatory Science Magazine was released. This online magazine, produced by the Medicines...
15-06-2017 | 15:00
The Medicines Evaluation Board (MEB) has described the terms and conditions which are to be used to assess applications for...
08-06-2017 | 09:00
The Medicines Evaluation Board (MEB) was one of the leading players in Europe in the field of medicine assessment and...
06-06-2017 | 13:00
As of 22 November 2017 new obligations in respect of signal management and reporting of suspected adverse reactions (ADRs) will...
02-06-2017 | 10:00
Mr Prof H. (Eric) Boersma was sworn in as a new member of the Medicines Evaluation Board (MEB) on 1 June 2017.
